Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia

Med Oncol. 2000 Nov;17(4):337-9. doi: 10.1007/BF02782201.

Abstract

Pathological rupture of the spleen is a rare but well recognized complication in hematological malignancies. Early clinical recognition of this life-threatening complication is necessary for rapid intervention. Here, we report on the case of a 26-year-old woman with acute promyelocytic leukemia who presented rupture of the spleen on day +2 of treatment with ATRA plus idarrubicin. In patients with acute leukemia, the presence of a painful abdomen and a sudden drop in hemoglobin levels, should alert of a possible splenic rupture, even without additional symptoms. This would facilitate an early treatment intervention with no modification to the chemotherapy schedule.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / etiology
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Leukemia, Promyelocytic, Acute / complications*
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Rupture, Spontaneous
  • Splenic Rupture / diagnosis
  • Splenic Rupture / etiology*
  • Tretinoin / administration & dosage

Substances

  • Tretinoin
  • Idarubicin